DUAL TRIPLE ART

View all the clinical researches

Collaboration on clinical research

Exploratory, open-label, randomized clinical trial to assess the efficacy of first-line dual vs. triple antiretroviral therapy (ART) in HIV-1 reservoir and in peripheral compartments in HIV-infected patients

01/01/2019 - 31/12/2022

Type of research: Exploratory, open-label, randomized clinical trial Principal Investigators: Javier Martínez-Picado, José Moltó Participating entities: Germans Trias i Pujol University Hospital, Fight Infections Foundation, IrsiCaixa AIDS Research Institute, University of North Carolina, Oregon Health & Sciences University

The study included 28 patients this year, reaching a total of 40 people recruited.

  • Disease: HIV/AIDS
  • Phase: III
  • CEIC Code: 2019-002733-10
  • Strategic line:
  • Funding: ViiV Healthcare

Subscribe to our newsletter

Back to Top
Irsi Caixa

Promoted by:

'La Caixa' Foundation Generalitat de Catalunya - Departament de Salut

 

HR Excellence in Research

Member of:

Cerca

In cooperation with: